Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies

References

• GilsonAMRyanKMJoransonDEDahlJLA reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002J Pain Symptom Manage20042817618815276196
   PubMed Web of Science ®Google Scholar
• ComptonWMVolkowNDMajor increases in opioid analgesic abuse in the United States: concerns and strategiesDrug Alcohol Depend20068110310716023304
   PubMed Web of Science ®Google Scholar
• Drug Abuse Warning NetworkHealth and Human Services (DHHS)National Estimates of Drug-related Emergency Department VisitsWashington, DCdepartment of Health and Human Services2004
   Google Scholar
• ElliottAMSmithBHPennyKISmithWCChambersWAThe epidemiology of chronic pain in the communityLancet19993541248125210520633
   PubMed Web of Science ®Google Scholar
• SchappertSMNational Ambulatory Medical Care Survey: 1989-summaryVital Health Stat 1319921101801376543
   PubMedGoogle Scholar
• StewartWFRicciJACheeEMorgansteinDLiptonRLost productive time and cost due to common pain conditions in the US workforceJAMA20032902443245414612481
   PubMed Web of Science ®Google Scholar
• TurkDCClinical effectiveness and cost-effectiveness of treatments for patients with chronic painClin J Pain20021835536512441829
   PubMed Web of Science ®Google Scholar
• JoransonDERyanKMGilsonAMDahlJLTrends in medical use and abuse of opioid analgesicsJAMA20002831710171410755497
   PubMed Web of Science ®Google Scholar
• IvesTJChelminskiPRHammett-StablerCAPredictors of opioid misuse in patients with chronic pain: a prospective cohort studyBMC Health Serv Res200664616595013
   PubMed Web of Science ®Google Scholar
• ReigerDAFarmerMERaeDSComorbidity of mental disorders with alcohol and other drug abuseJAMA1990264251125182232018
   PubMed Web of Science ®Google Scholar
• FishbainDAColeBLewisJRosomoffHLRosomoffRSWhat percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based reviewPain Med2008944445918489635
   PubMed Web of Science ®Google Scholar
• RosenblumAJosephHFongCKipnisSClelandCPortenoyRKPrevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilitiesJAMA20032892370237812746360
   PubMed Web of Science ®Google Scholar
• LarsonMJPaasche-OrlowMChengDMPersistent pain is associated with substance use after detoxification: a prospective cohort analysisAddiction200710275276017506152
   PubMed Web of Science ®Google Scholar
• OkieSA food of opioids, a rising tide of deathsN Engl J Med20103631981198521083382
   PubMed Web of Science ®Google Scholar
• MelzackRFrom the gate to the neuromatrixPain19996S121S12610491980
   PubMed Web of Science ®Google Scholar
• TurkDCOkifujiAPsychological factors in chronic pain: evolution and revolutionJ Consult Clin Psychol20027067869012090376
   PubMed Web of Science ®Google Scholar
• EisenbergerNILiebermanMDWilliamsKDDoes rejection hurt? An fMRI study of social exclusionScience200330229029214551436
   PubMed Web of Science ®Google Scholar
• WachholtzABPearceMJKoenigHGExploring the relationship between spirituality, coping, and painJ Behav Med20073031131817541817
   PubMed Web of Science ®Google Scholar
• BairMRobinsonRKatonWKroenkeKDepression and pain comorbidity: a literature reviewArch Intern Med20031632433244514609780
   PubMed Web of Science ®Google Scholar
• ZelmanDCHowlandEWNicholsSNCleelandCSThe effects of induced mood on laboratory painPain1991461051111896201
   PubMed Web of Science ®Google Scholar
• EdwardsRRHaythornthwaiteJASullivanMJFillingimRBCatastrophizing as a mediator of sex differences in pain: differential effects for daily pain versus laboratory-induced painPain200411133534115363877
   PubMed Web of Science ®Google Scholar
• KeefeFJLefebvreJCMaixnerWJrANS, Caldwell DS. Self-efficacy for arthritis pain: relationship to perception of thermal laboratory pain stimuliArthritis Care Res1997101771849335629
   PubMed Web of Science ®Google Scholar
• AdamsEHBreinerSCiceroTJA comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic painJ Pain Symptom Manage20063146547616716877
   PubMed Web of Science ®Google Scholar
• MartellBAO’ConnorPGKernsRDSystematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addictionAnn Intern Med200714611612717227935
   PubMed Web of Science ®Google Scholar
• HojstedJSjogrenPAddiction to opioids in chronic pain patients: a literature reviewEur J Pain20071149051817070082
   PubMed Web of Science ®Google Scholar
• MiottoKComptonPLingWConollyMDiagnosing addictive disease in chronic pain patientsPsychosomatics1996372232358849499
   PubMed Web of Science ®Google Scholar
• ComptonPDarakjianJMiottoKScreening for addiction in patients with chronic pain and “problematic” substance use: evaluation of a pilot assessment toolJ Pain Symptom Manage1998163553639879160
   PubMed Web of Science ®Google Scholar
• PortenoyRKHagenNABreakthrough pain: definition, prevalence and characteristicsPain1990412732811697056
   PubMed Web of Science ®Google Scholar
• BrodnerRATaubAChronic pain exacerbated by long-term narcotic use in patients with nonmalignant disease: clinical syndrome and treatmentMt Sinai J Med19784523323726869
   PubMedGoogle Scholar
• MathewNTKurmanRPerezFDrug induced refractory headache – clinical features and managementHeadache1990306346382272811
   PubMed Web of Science ®Google Scholar
• PortenoyRKChronic opioid therapy in nonmalignant painJ Pain Symptom Manage19905S46S621969892
   PubMedGoogle Scholar
• DunbarSAKatzNPChronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 casesJ Pain Symptom Manage1996111631718851374
   PubMed Web of Science ®Google Scholar
• Perdue PharmaDrug Safety and Risk Management Advisory Committee2009 Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Drug-SafetyandRiskManagementAdvisoryCommittee/UCM164897.pdfAccessed July 12, 2011
   Google Scholar
• LeeSParkYHanEThebaine in hair as a marker for chronic use of illegal opium poppy substancesForensic Sci Int201120411511820558018
   PubMed Web of Science ®Google Scholar
• HahmETKimYLeeJJChoYWGABAergic synaptic response and its opioidergic modulation in periaqueductal gray neurons of rats with neuropathic painBMC Neurosci2011124121569381
   PubMed Web of Science ®Google Scholar
• CorbettADHendersonGMcKnightATPatersonSJ75 years of opioid research: the exciting but vain quest for the Holy GrailBr J Pharmacol2006147Suppl 1S153S16216402099
   PubMed Web of Science ®Google Scholar
• OssipovMHLaiJKingTAntinociceptive and nociceptive actions of opioidsJ Neurobiol20046112614815362157
   PubMed Web of Science ®Google Scholar
• MollereauCParmentierMMailleuxPORL1, a novel member of the opioid receptor family. Cloning, functional expression and localizationFEBS Lett199434133388137918
   PubMed Web of Science ®Google Scholar
• ChevillardLMechanisms of respiratory insufficiency induced by methadone overdose in ratsAddict Biol200915628020002023
   PubMed Web of Science ®Google Scholar
• ArvidssonURiedlMChakrabartiSDistribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cordJ Neurosci1995155 Pt 1332833417751913
   PubMed Web of Science ®Google Scholar
• HolzerPOpioid receptors in the gastrointestinal tractRegul Pept2009155111719345246
   PubMed Web of Science ®Google Scholar
• FurlanADSandovalJAMailis-GagnonATunksEOpioids for chronic noncancer pain: a meta-analysis of effectiveness and side effectsCMAJ20061741589159416717269
   PubMed Web of Science ®Google Scholar
• GlassPSJhaveriRMSmithLRComparison of potency and duration of action of nalmefene and naloxoneAnesth Analg1994785365418109774
   PubMed Web of Science ®Google Scholar
• MooreRAMcQuayHJPrevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioidsArthritis Res Ther20057R1046R105116207320
   PubMed Web of Science ®Google Scholar
• EisenbergEMcNicolEDCarrDBEfficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: systematic review of randomized controlled trialsEur J Pain20061066767616337151
   PubMed Web of Science ®Google Scholar
• DaniellHWOpioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant painJ Pain20089283617936076
   PubMed Web of Science ®Google Scholar
• AngstMSClarkJDOpioid-induced hyperalgesia: a qualitative systematic reviewAnesthesiology200610457058716508405
   PubMed Web of Science ®Google Scholar
• VadiveluNMitraSHinesRLPeripheral opioid receptor agonists for analgesia: a comprehensive reviewJ Opioid Manag20117556821434585
   PubMedGoogle Scholar
• SamWJMacKeySCLotschJDroverDRMorphine and its metabolites after patient-controlled analgesia: considerations for respiratory depressionJ Clin Anesth20112310210621377072
   PubMed Web of Science ®Google Scholar
• HerveraANegreteRLeanezSMartin-CamposJMPolOPeripheral effects of morphine and expression of mu-opioid receptors in the dorsal root ganglia during neuropathic pain: nitric oxide signalingMol Pain201172521486477
   PubMed Web of Science ®Google Scholar
• KirchheinerJSchmidtHTzvetkovMPharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplicationPharmacogenomics J2007725726516819548
   PubMed Web of Science ®Google Scholar
• FosterDUptonRChristrupLPopperLPharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgeryAnn Pharmacother2008421380138718728103
   PubMed Web of Science ®Google Scholar
• JumbelicMIDeaths with transdermal fentanyl patchesAm J Forensic Med Pathol201031182119918162
   PubMed Web of Science ®Google Scholar
• DhallaIAMamdaniMMSivilottiMLKoppAQureshiOJuurlinkDNPrescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodoneCMAJ200918189189619969578
   PubMed Web of Science ®Google Scholar
• WardJBellJMattickRPMethadone maintenance treatment and other opioid replacement therapiesMethadone Maintenance Therapy for Opioid Dependence: A Guide to Appropriate UseWardJMattickRPHallWSydney, AustraliaHarwood Academic Publishers1996
   Google Scholar
• BrownRKrausCFlemingMReddySMethadone: applied pharmacology and use as adjunctive treatment in chronic painPostgrad Med J20048065465915537850
   PubMed Web of Science ®Google Scholar
• BlindermanCDSekineRZhangBNillsonMShaiovaLMethadone as an analgesic for patients with chronic pain in methadone maintenance treatment programs (MMTPs)J Opioid Manag2009510711419507807
   PubMedGoogle Scholar
• RhodinAGronbladhLNilssonLHGordhTMethadone treatment of chronic non-malignant pain and opioid dependence – a long-term follow-upEur J Pain20061027127815972261
   PubMed Web of Science ®Google Scholar
• KrantzMJHeterogeneous impact of methadone on the QTc interval: what are the practical implications?J Addict Dis2008275919042586
   PubMed Web of Science ®Google Scholar
• KrantzMJMartinJStimmelBMehtaDHaigneyMCQTc interval screening in methadone treatmentAnn Intern Med200915038739519153406
   PubMed Web of Science ®Google Scholar
• MartellBAArnstenJHRayBGourevitchMNThe impact of methadone induction on cardiac conduction in opiate usersAnn Intern Med200313915415512859171
   PubMed Web of Science ®Google Scholar
• CrucianiRASekineRHomelPMeasurement of QTc in patients receiving chronic methadone therapyJ Pain Symptom Manage20052938539115857742
   PubMed Web of Science ®Google Scholar
• BruceRDPharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practiceJ Acquir Immune Defic Syndr20064156357216652030
   PubMed Web of Science ®Google Scholar
• PerretGDeglonJJKreekMJHoALaHRLethal methadone intoxications in Geneva, Switzerland, from 1994 to 1998Addiction2000951647165311219368
   PubMed Web of Science ®Google Scholar
• MattickRPBreenCKimberJDavoliMMethadone maintenance therapy versus no opioid replacement therapy for opioid dependenceCochrane Database Syst Rev20032CD00220912804430
   PubMedGoogle Scholar
• CooperJRIncluding narcotic addiction treatment in an office-based practiceJAMA1995273161916207745777
   PubMed Web of Science ®Google Scholar
• NovickDMJosephHSalsitzEAOutcomes of treatment of socially rehabilitated methadone maintenance patients in physicians’ offices (medical maintenance): follow-up at three and a half to nine and a fourth yearsJ Gen Intern Med199491271308195910
   PubMed Web of Science ®Google Scholar
• NovickDMPascarelliEFJosephHMethadone maintenance patients in general medical practice. A preliminary reportJAMA1988259329933023373662
   PubMed Web of Science ®Google Scholar
• GrahamNAMerloLJGoldbergerBAGoldMSMethadone- and heroin-related deaths in FloridaAm J Drug Alcohol Abuse20083434735318428077
   PubMed Web of Science ®Google Scholar
• FudalaPJYuEMacfaddenWBoardmanCChiangCNEffects of buprenorphine and naloxone in morphine-stabilized opioid addictsDrug Alcohol Depend199850189589267
   PubMed Web of Science ®Google Scholar
• KuhlmanJJJrLevineBJohnsonREFudalaPJConeEJRelationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphineAddiction1998935495599684393
   PubMed Web of Science ®Google Scholar
• AmassLKamienJBMikulichSKThrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humansDrug Alcohol Depend20016117318111137282
   PubMed Web of Science ®Google Scholar
• PetryNMBickelWKBadgerGJExamining the limits of the buprenorphine interdosing interval: daily, every-third-day and every-fifth-day dosing regimensAddiction20019682383411399214
   PubMed Web of Science ®Google Scholar
• WalshSLPrestonKLStitzerMLConeEJBigelowGEClinical pharmacology of buprenorphine: ceiling effects at high dosesClin Pharmacol Ther1994555695808181201
   PubMed Web of Science ®Google Scholar
• WalshSLPrestonKLBigelowGEStitzerMLAcute administration of buprenorphine in humans: partial agonist and blockade effectsJ Pharmacol Exp Ther19952743613727542336
   PubMed Web of Science ®Google Scholar
• LangeWRFudalaPJDaxEMJohnsonRESafety and side-effects of buprenorphine in the clinical management of heroin addictionDrug Alcohol Depend19902619282209411
   PubMed Web of Science ®Google Scholar
• HuestisMAUmbrichtAPrestonKLSafety of buprenorphine: no clinically relevant cardio-respiratory depression at high IV dosesProblems of Drug DependenceHarrisLSWashington, DCUS Government Printing Office1999
   Google Scholar
• PergolizziJBogerRHBuddKOpioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone)Pain Pract2008828731318503626
   PubMedGoogle Scholar
• BallantyneJCLaForgeKSOpioid dependence and addiction during opioid treatment of chronic painPain200712923525517482363
   PubMed Web of Science ®Google Scholar
• JohnsonREFudalaPJPayneRBuprenorphine: considerations for pain managementJ Pain Symptom Manage20052929732615781180
   PubMed Web of Science ®Google Scholar
• LingWCharuvastraCCollinsJFBuprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trialAddiction1998934754869684386
   PubMed Web of Science ®Google Scholar
• FiellinDAPantalonMVPakesJPO’ConnorPGChawarskiMSchottenfeldRSTreatment of heroin dependence with buprenorphine in primary careAm J Drug Alcohol Abuse20022823124112014814
   PubMed Web of Science ®Google Scholar
• McDiarmidTMacklerLSchneiderDMClinical inquiries. What is the addiction risk associated with tramadol?J Fam Pract200554727315623411
   PubMedGoogle Scholar
• KroenkeKKrebsEEBairMJPharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviewsGen Hosp Psychiatry20093120621919410099
   PubMed Web of Science ®Google Scholar
• GonzalezGOlivetoAKostenTRCombating opiate dependence: a comparison among the available pharmacological optionsExpert Opin Pharmacother2004571372515102558
   PubMed Web of Science ®Google Scholar
• SilvermanSMOpioid induced hyperalgesia: clinical implications for the pain practitionerPain Physician20091267968419461836
   PubMed Web of Science ®Google Scholar
• KasimcanOKaptanHEfficacy of gabapentin for radiculopathy caused by lumbar spinal stenosis and lumbar disk herniaNeurol Med Chir (Tokyo)2010501070107321206180
   PubMed Web of Science ®Google Scholar
• UcakAOnanBSenHSelcukITuranAYilmazATThe effects of gabapentin on acute and chronic postoperative pain after coronary artery bypass graft surgeryJ Cardiothorac Vasc Anesth1112011 [Epub ahead of print]
   Web of Science ®Google Scholar
• FolkessonAHonorePHAndersenLMKristensenPBjerrumOJLow dose of donepezil improves gabapentin analgesia in the rat spared nerve injury model of neuropathic pain: single and multiple dosing studiesJ Neural Transm20101171377138520890617
   PubMed Web of Science ®Google Scholar
• CroffordLJRowbothamMCMeasePJPregabalin for the treatment of fibromyalgia syndrome: results of a randomized, doubleblind, placebo-controlled trialArthritis Rheum2005521264127315818684
   PubMed Web of Science ®Google Scholar
• ArnoldLMRussellIJDiriEWA 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgiaJ Pain2008979280518524684
   PubMed Web of Science ®Google Scholar
• CroffordLJMeasePJSimpsonSLFibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalinPain200813641943118400400
   PubMed Web of Science ®Google Scholar
• MeasePJRussellIJArnoldLMA randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgiaJ Rheumatol20083550251418278830
   PubMed Web of Science ®Google Scholar
• ReclaJMNew and emerging therapeutic agents for the treatment of fibromyalgia: an updateJ Pain Res201038910321197313
   PubMedGoogle Scholar
• PDR Network LLCAvailable from: http://www.pdr.net/drugpages/productlabeling.aspx?mpcode=62950900Accessed July 13, 2011
   Google Scholar
• FilipettoFAZippCPCorenJSPotential for pregabalin abuse or diversion after past drug-seeking behaviorJ Am Osteopath Assoc201011060560721068226
   PubMedGoogle Scholar
• ArnoldLMLuYCroffordLJA double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorderArthritis Rheum2004502974298415457467
   PubMed Web of Science ®Google Scholar
• ArnoldLMRosenAPritchettYLA randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorderPain200511951516298061
   PubMed Web of Science ®Google Scholar
• ChappellASBradleyLAWiltseCDetkeMJD’SouzaDNSpaethMA six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgiaInt J Gen Med200919110220428412
   PubMedGoogle Scholar
• MeasePJRussellIJKajdaszDKLong-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgiaSemin Arthritis Rheum20103945446419152958
   PubMed Web of Science ®Google Scholar
• RussellIJMeasePJSmithTREfficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trialPain200813643244418395345
   PubMed Web of Science ®Google Scholar
• ArnoldLMClauwDJWohlreichMMEfficacy of duloxetine in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trialsPrim Care Companion J Clin Psychiatry20091123724419956462
   PubMedGoogle Scholar
• GredenJFDuloxetine and milnacipranSchatzbergAFNemeroffCBEssentials of Clinical Psychopharmacology2nd edArlington, VAAmerican Psychiatric Publishing Inc2006
   Google Scholar
• ShutoSOnoSHaseYSynthesis and biological activity of conformationally restricted analogs of milnacipran: (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide, an efficient noncompetitive N-methyl-D-aspartic acid receptor antagonistJ Med Chem199639484448528941398
   PubMed Web of Science ®Google Scholar
• NebelMBGracelyRHNeuroimaging of fibromyalgiaRheum Dis Clin North Am20093531332719647145
   PubMed Web of Science ®Google Scholar
• NagaokaSOhnoMSekiguchiAAn open-label clinical trial of milnacipran in fibromyalgia syndrome with co-morbid depressive symptomsInt Clin Psychiatry Clin Pract200484751
   PubMed Web of Science ®Google Scholar
• BrancoJCZachrissonOPerrotSMainguyYA European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgiaJ Rheumatol20103785185920156949
   PubMed Web of Science ®Google Scholar
• VittonOGendreauMGendreauJKranzlerJRaoSGA double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgiaHum Psychopharmacol200419Suppl 1S27S3515378666
   PubMed Web of Science ®Google Scholar
• DharmshaktuPTayalVKalraBSEfficacy of antidepressants as analgesics: a reviewJ Clin Pharmacol3172011 [Epub ahead of print]
   Web of Science ®Google Scholar
• McQuayHJTramérMNyeBACarrollDWiffenPJMooreRAA systematic review of antidepressants in neuropathic painPain1996682172279121808
   PubMed Web of Science ®Google Scholar
• MeliefEJMiyatakeMBruchasMRChavkinCLigand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signalingProc Natl Acad Sci U S A2010107116081161320534436
   PubMed Web of Science ®Google Scholar
• ChavkinCThe therapeutic potential of kappa-opioids for treatment of pain and addictionNeuropsychopharmacology20113636937021116263
   PubMed Web of Science ®Google Scholar
• LiXYKoHGChenTAlleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortexScience20103301400140421127255
   PubMed Web of Science ®Google Scholar
• ProchaskaJODiClementeCCToward a comprehensive model of changeMillerWHeatherNTreating Addictive Behavior: Processes of ChangeNew York, NYPlenum Press1986
   Google Scholar
• SavageSAssessment for addiction in pain-treatment settingsClin J Pain200218S28S3812479252
   PubMed Web of Science ®Google Scholar
• EcclestonCRole of psychology in pain managementBr J Anaesth20018714415211460803
   PubMed Web of Science ®Google Scholar
• RounsavilleBJCarrollKMIndividual psychotherapy for drug abusersLowinsohnJRuizPMillerRComprehensive Textbook of Substance AbuseNew York, NYWilliams and Wilkins1997
   Google Scholar
• CheatleMDGallagherRMChronic pain and comorbid mood and substance use disorders: a biopsychosocial treatment approachCurr Psychiatry Rep2006837137616968617
   PubMedGoogle Scholar
• FordyceWEBehavioral Methods for Chronic Pain and IllnessSaint Louis, MOMosby1976
   Google Scholar
• MoltonIRGStoelbCJensenBLCurrent psychological approaches to the management of chronic painCurr Opin Anasthesiol200720485489
   PubMed Web of Science ®Google Scholar
• StitzerMPetryNContingency management for treatment of substance abuseAnnu Rev Clin Psychol2006241143417716077
   PubMed Web of Science ®Google Scholar
• MayetSFarrellMFerriMMFAmatoLDavoliMPsychosocial treatment for opiate abuse and dependenceCochrane Database Syst Rev20051CD00433015744796
   PubMed Web of Science ®Google Scholar
• SeyboldKPhysiological mechanisms involved in religiosity/spirituality and healthJ Behav Med20073030330917549618
   PubMed Web of Science ®Google Scholar
• National Institutes of HealthNIH Consensus Development Conference on AcupunctureJAMA1998280151815249809733
   PubMed Web of Science ®Google Scholar
• EzzoJBermanBHadhazyVAJadadARLaoLSinghBBIs acupuncture effective for the treatment of chronic pain? A systematic reviewPain20008621722510812251
   PubMed Web of Science ®Google Scholar
• ArnoldRMAvantsSKMargolinAMarcotteDPatient attitudes concerning the inclusion of spirituality into addiction treatmentJ Subst Abuse Treat20022331932612495793
   PubMed Web of Science ®Google Scholar
• BarryDTBeitelMCutterCJJoshiDFalcioniJSchottenfeldRConventional and nonconventional pain treatment utilization among opioid dependent individuals with pain seeking methadone maintenance treatment: a needs assessment studyJ Addict Med200918379385
   Google Scholar
• CarsonJKeefeFLynchTLoving-kindness meditation for chronic low back pain: results from a pilot trialJ Holist Nurs20052328730416049118
   PubMedGoogle Scholar
• MoroneNEGrecoCMMind-body interventions for chronic pain in older adults: a structured reviewPain Med2007835937517610459
   PubMed Web of Science ®Google Scholar
• WachholtzAPargamentKMigraines and meditation: does spirituality matter?J Behav Med20083135136618551362
   PubMed Web of Science ®Google Scholar
• DaleyDCMarlattGARelapse prevention: cognitive and behavioral interventionsLowinsonJHRuizPMillmanRBLangrodJGSubstance Abuse: A Comprehensive Textbook2nd edBaltimore, MDWilliams and Wilkins1992
   Google Scholar
• VallejoZAmaroHAdaptation of mindfulness-based stress reduction program for addiction relapse preventionThe Humanistic Psychologist200937192206
   Google Scholar
• Kabat-ZinnJLipworthLBurneyRSellersWFour-year follow-up of a meditation based program for the self-regulation of chronic pain: treatment outcomes and complianceClin J Pain19862159173
   Google Scholar
• RosenzweigSGreesonJMReibelDKGreenJSJasserSABeasleyDMindfulness-based stress reduction for chronic pain conditions: variation in treatment outcomes and role of home meditation practiceJ Psychosom Res201068293620004298
   PubMed Web of Science ®Google Scholar
• ZgierskaARabagoDChawlaNKushnerKKoehlerRMarlattAMindfulness meditation for substance use disorders: a systematic reviewSubst Abuse200930266294
   PubMed Web of Science ®Google Scholar
• ZiedonisDMBermanJLehnMDCoamecoSSupport groups and twelve-step programs in the treatment of the chronic pain patientPain and Chemical DependencySmithHSPassikSDNew York, NYOxford University Press2008
   Google Scholar
• MartelliMLiljedahlENicholsonKZaslerNA brief introductory guide to chronic pain resources on the InternetNeuroRehabilitation20001410512111455073
   PubMed Web of Science ®Google Scholar
• American Chronic Pain AssociationTen Steps2011 Available from: http://www.theacpa.org/21/TenSteps.aspxAccessed May 6, 2011
   Google Scholar
• DavisWJohnsonBPrescription opioid use, misuse, and diversion among street drug users in New York CityDrug Alcohol Depend2008922677617913395
   PubMed Web of Science ®Google Scholar
• EzykBPrescription drug monitoring programs2008 Available from: http://www.codrugfreeworkplace.org/files/documents/White%20paper%20-PDMP%207-08%20with%20logos.pdfAccessed March 2, 2011
   Google Scholar